PLoS ONE (Jan 2014)

Endurance capacity is not correlated with endothelial function in male university students.

  • Yan Wang,
  • Xian-bo Zeng,
  • Feng-juan Yao,
  • Fang Wu,
  • Chen Su,
  • Zhen-guo Fan,
  • Zhu Zhu,
  • Jun Tao,
  • Yi-jun Huang

DOI
https://doi.org/10.1371/journal.pone.0103814
Journal volume & issue
Vol. 9, no. 8
p. e103814

Abstract

Read online

BACKGROUND: Endurance capacity, assessed by 1000-meter (1000 m) run of male university students, is an indicator of cardiovascular fitness in Chinese students physical fitness surveillance. Although cardiovascular fitness is related to endothelial function closely in patients with cardiovascular diseases, it remains unclear whether endurance capacity correlates with endothelial function, especially with circulating endothelial microparticles (EMPs), a new sensitive marker of endothelial dysfunction in young students. The present study aimed to investigate the relationship between endurance capacity and endothelial function in male university students. METHODS: Forty-seven healthy male university students (mean age, 20.1 ± 0.6 years; mean height, 172.4 ± 6.3 cm; and mean weight, 60.0 ± 8.2 kg) were recruited in this study. The measurement procedure of 1000 m run time was followed to Chinese national students Constitutional Health Criterion. Endothelium function was assessed by flow-mediated vasodilation (FMD) in the brachial artery measured by ultrasonic imaging, and the level of circulating EMPs was measured by flow cytometry. Cardiovascular fitness indicator--maximal oxygen uptake (VO2max)--was also measured on a cycle ergometer using a portable gas analyzer. RESULTS: 1000 m run time was correlated with VO2max (r = -0.399, p0.05). CONCLUSION: The correlations between endurance capacity or cardiovascular fitness and endothelial function were not found in healthy Chinese male university students. These results suggest that endurance capacity may not reflect endothelial function in healthy young adults with well preserved FMD and low level of circulating CD31+/CD42-EMPs.